HIV therapeutic vaccine data

The Carlsbad, Calif., company and partner Rhone-Poulenc Rorer Inc. published results of a one-year, Phase II/III trial showing effects in 103 patients on early markers of infection,

The results, partially discussed at last year's international AIDS conference in Berlin, included slowing in the rise in viral load, a smaller decline in CD4 counts and a slowed decline in functioning of cells of the immune system. ...